TY - JOUR
T1 - Association of the translocation (15;17) with malignant proliferation of promyelocytes in acute leukemia and chronic myelogenous leukemia at blastic crisis
AU - Misawa, S.
AU - Lee, E.
AU - Schiffer, C. A.
AU - Liu, Z.
AU - Testa, J. R.
PY - 1986/2
Y1 - 1986/2
N2 - Cytogenetic studies were performed on nine patients with acute promyelocytic leukemia. Every patient had an identical translocation (15;17) or, in one case, a variant three-way rearrangement between chromosomes 7, 15, and 17. Another patient with chronic myelogenous leukemia was examined at the time of blastic crisis when the patient's bone marrow was infiltrated by hypergranular promyelocytes and blasts. Bone marrow cells contained a t(15;17) as well as a Ph1 chromosome. Only the latter abnormality was observed in the chronic phase of the disease. The translocation (15;17) was detected in all ten patients when bone marrow or peripheral blood cells were cultured for 24 hours prior to making chromosome preparations. However, the t(15;17) was not seen in three of these same cases when bone marrow cells were processed directly. These findings indicate that the t(15;17) is closely associated with acute proliferation of leukemic promyelocytes and that detection of this karyotypic defect may be influenced by the particular cytogenetic processing method used in different laboratories. An analysis of the banding pattern in the variant translocation provided additional evidence favoring chromosomal breakpoints at or very near the junction between bands 17q12 and 17q21 and at 15q22.
AB - Cytogenetic studies were performed on nine patients with acute promyelocytic leukemia. Every patient had an identical translocation (15;17) or, in one case, a variant three-way rearrangement between chromosomes 7, 15, and 17. Another patient with chronic myelogenous leukemia was examined at the time of blastic crisis when the patient's bone marrow was infiltrated by hypergranular promyelocytes and blasts. Bone marrow cells contained a t(15;17) as well as a Ph1 chromosome. Only the latter abnormality was observed in the chronic phase of the disease. The translocation (15;17) was detected in all ten patients when bone marrow or peripheral blood cells were cultured for 24 hours prior to making chromosome preparations. However, the t(15;17) was not seen in three of these same cases when bone marrow cells were processed directly. These findings indicate that the t(15;17) is closely associated with acute proliferation of leukemic promyelocytes and that detection of this karyotypic defect may be influenced by the particular cytogenetic processing method used in different laboratories. An analysis of the banding pattern in the variant translocation provided additional evidence favoring chromosomal breakpoints at or very near the junction between bands 17q12 and 17q21 and at 15q22.
KW - Bone Marrow/pathology
KW - Cell Cycle
KW - Chromosome Banding
KW - Chromosomes, Human, 13-15
KW - Chromosomes, Human, 16-18
KW - Humans
KW - Karyotyping
KW - Leukemia, Myeloid, Acute/genetics
KW - Leukemia, Myeloid/genetics
KW - Translocation, Genetic
UR - https://www.scopus.com/pages/publications/0022633597
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:A1986AZK8500003&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1182/blood.v67.2.270.bloodjournal672270
DO - 10.1182/blood.v67.2.270.bloodjournal672270
M3 - Article
C2 - 3455826
SN - 0006-4971
VL - 67
SP - 270
EP - 274
JO - Blood
JF - Blood
IS - 2
ER -